Haemonetics Corp (HAE)

SG&A Expenses

$449.95M

TTM · Period ending: · USD

HAE logo

HAE SG&A Expenses

Latest reported$449.95M
HAE TTM SG&A Expenses ($44.20M → $449.95M)
High-resolution chart · PNG

HAE sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Haemonetics Corp SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
449,947,000
331,006,000
323,679,000
216,120,000
114,501,000
114,501,000
115,123,000
115,123,000
115,123,000
115,123,000
95,426,000
95,426,000
95,426,000
95,426,000
96,405,000
96,405,000
96,405,000
96,405,000
60,052,000
60,052,000
60,052,000
60,052,000
38,354,000
116,145,000
193,562,000
265,766,000
306,019,000
302,105,000
301,936,000
298,277,000
298,694,000
322,672,000
318,207,000
316,523,000
309,202,000
282,752,000
281,087,000
301,726,000
306,300,000
313,835,000
317,282,000
317,394,000
320,719,000
324,537,000
334,741,000
339,691,000
349,048,000
355,850,000
352,589,000
366,838,000
365,493,000
362,713,000
362,239,000
323,053,000
300,479,000
275,075,000
256,654,000
245,260,000
230,040,000
225,599,000
215,776,000
213,899,000
228,103,000
224,319,000
218,998,000
214,483,000
207,516,000
202,330,000
200,724,000
198,744,000
185,385,000
178,852,000
171,535,000
163,115,000
151,232,000
143,410,000
139,605,000
137,074,000
134,769,000
132,409,000
127,771,000
121,351,000
124,514,000
123,161,000
120,443,000
118,039,000
114,616,000
109,664,000
110,131,000
108,450,000
104,449,000
103,990,000
100,092,000
97,705,000
94,223,000
93,020,000
90,925,000
88,915,000
89,269,000
88,811,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.